Want to join the conversation?
$DGX 2Q15 Call: Consolidated revenues of $1.93Bil, increased by 1.2% versus prior year; & grew organically by 80BP. Revenues for Diagnostic Information Services grew by 0.4% compared to prior year. Volume measured by number of requisitions declined by 0.4% versus prior year. However, revenue per acquisition was 0.9% better than the prior year.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.